Nuvectis Pharma annual net income
2021
2022
2023
2024
2025
Nuvectis Pharma Net Income Growth & History (NVCT)
Nuvectis Pharma's net income was −$26.4M for fiscal 2025.
View full Nuvectis Pharma company overviewNuvectis Pharma annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$26.4M | −$7.4M | — |
| 2024 | 2024-12-31 | −$19.0M | $3.3M | — |
| 2023 | 2023-12-31 | −$22.3M | −$3.2M | — |
| 2022 | 2022-12-31 | −$19.1M | −$6.2M | — |
| 2021 | 2021-12-31 | −$12.9M | — | — |
Nuvectis Pharma quarterly net income
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$7.0M | −$686,000 | — |
| Q1 2026 | 2026-03-31 | −$6.0M | −$718,000 | — |
| Q4 2025 | 2025-12-31 | −$7.3M | −$1.1M | — |
| Q3 2025 | 2025-09-30 | −$7.5M | −$3.3M | — |
| Q2 2025 | 2025-06-30 | −$6.3M | −$1.9M | — |
| Q1 2025 | 2025-03-31 | −$5.3M | −$1.2M | — |
| Q4 2024 | 2024-12-31 | −$6.2M | $374,000 | — |
| Q3 2024 | 2024-09-30 | −$4.2M | $1.7M | — |
| Q2 2024 | 2024-06-30 | −$4.4M | $1.3M | — |
| Q1 2024 | 2024-03-31 | −$4.2M | −$122,000 | — |
| Q4 2023 | 2023-12-31 | −$6.6M | $74,000 | — |
| Q3 2023 | 2023-09-30 | −$5.9M | −$4,000 | — |
| Q2 2023 | 2023-06-30 | −$5.7M | −$2.1M | — |
| Q1 2023 | 2023-03-31 | −$4.0M | −$1.1M | — |
| Q4 2022 | 2022-12-31 | −$6.7M | −$4.4M | — |
| Q3 2022 | 2022-09-30 | −$5.9M | −$1.2M | — |
| Q2 2022 | 2022-06-30 | −$3.6M | $2.4M | — |
| Q1 2022 | 2022-03-31 | −$2.9M | −$2.9M | — |
| Q4 2021 | 2021-12-31 | −$2.3M | — | — |
| Q3 2021 | 2021-09-30 | −$4.7M | — | — |
| Q2 2021 | 2021-06-30 | −$5.9M | — | — |
| Q1 2021 | 2021-03-31 | −$23,000 | — | — |
Nuvectis Pharma net income trends
Between the periods ended 2021-12-31 and 2025-12-31, Nuvectis Pharma's net income decreased from −$12.9M to −$26.4M, a change of −$13.6M. The latest reported quarter, Q2 2026, shows −$7.0M.
About the metric
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
Calculation and source
SEC-reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company SEC filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nuvectis Pharma source filings ↗Community posts
Nuvectis’ partner reports expanded glioma responses for experimental BRAF inhibitor
Nuvectis ($NVCT) reported expanded Phase 1b results for NXP200 from partner Haisco’s Chinese study in recurrent or progressive BRAF V600-mutated glioma. Tumor responses occurred in eight of twenty evaluable patients with high-grade disease ...
